James K. Burmester

2.7k total citations
44 papers, 1.8k citations indexed

About

James K. Burmester is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, James K. Burmester has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Pharmacology. Recurrent topics in James K. Burmester's work include Pharmacogenetics and Drug Metabolism (9 papers), TGF-β signaling in diseases (9 papers) and Pancreatic and Hepatic Oncology Research (4 papers). James K. Burmester is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), TGF-β signaling in diseases (9 papers) and Pancreatic and Hepatic Oncology Research (4 papers). James K. Burmester collaborates with scholars based in United States, Canada and United Kingdom. James K. Burmester's co-authors include Ingrid Glurich, Michael D. Caldwell, Russell A. Wilke, Richard L. Berg, Steven H. Yale, John R. Schmelzer, Jason H. Moore, William J. Catàlona, Brian K. Suarez and John S. Witte and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

James K. Burmester

44 papers receiving 1.8k citations

Peers

Countries citing papers authored by James K. Burmester

Since Specialization

Citations

This map shows the geographic impact of James K. Burmester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James K. Burmester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James K. Burmester more than expected).

Fields of papers citing papers by James K. Burmester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James K. Burmester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James K. Burmester. The network helps show where James K. Burmester may publish in the future.

Co-authorship network of co-authors of James K. Burmester

This figure shows the co-authorship network connecting the top 25 collaborators of James K. Burmester. A scholar is included among the top collaborators of James K. Burmester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James K. Burmester. James K. Burmester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously diagnosed with Menetrier's disease 2016 ·Digestive and Liver Disease ·James K. Burmester, Lauren Bell, Deanna Cross, Patrick Meyer, Steven H. Yale	11
2	Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial 2012 ·Breast Cancer Research and Treatment ·Catherine A. McCarty, Douglas J. Reding, John Commins, Craig Williams, Meredith Yeager, James K. Burmester, Catherine Schairer, Regina G. Ziegler	16
3	A randomized controlled trial of genotype-based Coumadin initiation 2011 ·Genetics in Medicine ·James K. Burmester, Richard L. Berg, Steven H. Yale, (unknown), Ingrid Glurich, John R. Schmelzer, Michael D. Caldwell	93
4	Lack of association between polymorphisms in the prostaglandin F_2αreceptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs 2011 ·Ophthalmic Genetics ·Catherine A. McCarty, Richard L. Berg, (unknown), Russell A. Wilke, James K. Burmester	13
5	Understanding the pharmacogenetic approach to warfarin dosing 2008 ·Heart Failure Reviews ·Ingrid Glurich, James K. Burmester, Michael D. Caldwell	26
6	Intraocular Pressure Response to Medication in a Clinical Setting: The Marshfield Clinic Personalized Medicine Research Project 2008 ·Journal of Glaucoma ·Catherine A. McCarty, Bickol N. Mukesh, Terrie Kitchner, William C. Hubbard, Russell A. Wilke, James K. Burmester, (unknown)	25
7	Lack of evidence of WNT3A as a candidate gene for congenital vertebral malformations 2007 ·Scoliosis ·Nader Ghebranious, Cathleen Raggio, Robert D. Blank, Elizabeth McPherson, James K. Burmester, Lynn Ivacic, (unknown), (unknown), Ingrid Glurich, F. Stig Jacobsen, Thomas Faciszewski, Richard M. Pauli, Oheneba Boachie-Adjei, Philip F. Giampietro	15
8	DLL3 as a candidate gene for vertebral malformations 2006 ·American Journal of Medical Genetics Part A ·Philip F. Giampietro, Cathleen Raggio, (unknown), Nader Ghebranious, James K. Burmester, Ingrid Glurich, (unknown), Elizabeth McPherson, Richard M. Pauli, Sanjay K. Shukla, (unknown), F. Stig Jacobsen, Thomas Faciszewski, Robert D. Blank	28
9	Small Molecule Antagonists of the TGF-β1/TGF-β Receptor Binding Interaction 2006 ·Medical Oncology ·James K. Burmester, (unknown), (unknown), Richard A. Dart	4
10	Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage 2005 ·Pharmacogenetics and Genomics ·Russell A. Wilke, Jason H. Moore, James K. Burmester	105
11	Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype 2004 ·Pharmacogenetics ·(unknown), Russell A. Wilke, Michael D. Caldwell, Richard L. Berg, Ingrid Glurich, James K. Burmester	114
12	Genome‐wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci 2003 ·The Prostate ·John S. Witte, Brian K. Suarez, Bonnie Thiel, Jennifer Lin, Adong Yu, Tarit K. Banerjee, James K. Burmester, Graham Casey, William J. Catàlona	42
13	Amino acids 67 and 68 of transforming growth factor-β regulate binding to a glycosyl phosphatidyl inositol-linked membrane protein on vascular endothelial cells 2002 ·PubMed ·(unknown), (unknown), (unknown), James K. Burmester	5
14	Regulation of colony-stimulating factor-induced human myelopoiesis by transforming growth factor-β isoforms 2002 ·PubMed ·(unknown), Joseph J. Mazza, James K. Burmester	8
15	Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome 2000 ·European Journal of Human Genetics ·Naomichi Matsumoto, Donna E. David, Eric W. Johnson, David Konecki, James K. Burmester, David H. Ledbetter, James L. Weber	26
16	Genomewide Scan for Prostate Cancer–Aggressiveness Loci 2000 ·The American Journal of Human Genetics ·John S. Witte, Katrina A.B. Goddard, David V. Conti, Robert C. Elston, Jennifer Lin, Brian K. Suarez, Karl W. Broman, James K. Burmester, James L. Weber, William J. Catàlona	115
17	Distinct Functional Domains of TGF-β Bind Receptors on Endothelial Cells 1999 ·Growth Factors ·Su Wen Qian, Nancy Dumont, Maureen D. O'Connor‐McCourt, James K. Burmester	10
18	Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia 1999 ·Medical Oncology ·William R. Friedenberg, (unknown), (unknown), James K. Burmester	10
19	Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor Gene 1995 ·Journal of Biological Chemistry ·Hyun W. Bae, Andrew G. Geiser, David H. Kim, Michelle Chung, James K. Burmester, Michael B. Sporn, Anita B. Roberts, Seong‐Jin Kim	109
20	Characterization of Mutated Transforming Growth Factor-.beta.s Which Possess Unique Biological Properties 1994 ·Biochemistry ·Su Wen Qian, James K. Burmester, Peter D. Sun, (unknown), (unknown), Laurent Suardet, Kathleen C. Flanders, David R. Davies, Anita B. Roberts, Michael B. Sporn	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact